Eikon Therapeutics, Inc. (EIKN)Healthcare | Biotechnology | Millbrae, United States | NasdaqGS
10.98 USD
-0.54
(-4.688%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 10.98 |
Hot Take ↕ | Aug. 22, 2026, 6:01 a.m. EDT
The immediate outlook is neutral due to conflicting signals: while the stock recently rallied off its lows, the statistical forecast model offers no directional edge with low confidence, suggesting the recent move may be noise rather than a trend. Fundamentally, the company faces significant headwinds with negative earnings, negative operating cash flow, and a forward P/E that indicates no near-term profitability. The balance sheet shows a healthy liquidity cushion with a current ratio near 10x, which prevents an immediate distress scenario, but the lack of revenue growth and persistent losses make a 'buy' thesis difficult to construct without a specific catalyst. On the long-term horizon, the absence of any multi-year price history prevents an assessment of structural trends, leaving the investment case reliant entirely on future clinical developments and management execution rather than proven business quality. Consequently, there is no compelling reason to overweight the position for either short-term traders or long-term holders at these levels. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.079542 |
| AutoETS | 0.081115 |
| AutoARIMA | 0.081115 |
| AutoTheta | 0.128220 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 0.28 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.027 |
| Excess Kurtosis | 0.18 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 54.066 |
| Market Cap | 594,732,032 |
| Forward P/E | -1.73 |
| Website | https://eikontx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.268 |
| Address1 | 230 Harriet Tubman Way |
| All Time High | 17.4 |
| All Time Low | 7.9 |
| Ask | 11.09 |
| Ask Size | 1 |
| Average Analyst Rating | 2.0 - Buy |
| Average Daily Volume10 Day | 545,290 |
| Average Daily Volume3 Month | 403,326 |
| Average Volume | 403,326 |
| Average Volume10Days | 545,290 |
| Bid | 8.2 |
| Bid Size | 2 |
| Book Value | 8.615 |
| City | Millbrae |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 10.98 |
| Current Ratio | 9.892 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 11.44 |
| Day Low | 10.9 |
| Debt To Equity | 54.066 |
| Display Name | Eikon Therapeutics |
| Earnings Timestamp | 1,786,651,200 |
| Earnings Timestamp End | 1,794,513,600 |
| Earnings Timestamp Start | 1,794,513,600 |
| Ebitda | -317,228,992 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.995 |
| Enterprise Value | 315,773,024 |
| Eps Current Year | -6.41162 |
| Eps Forward | -6.33429 |
| Eps Trailing Twelve Months | -5.65 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 10.4894 |
| Fifty Day Average Change | 0.49059963 |
| Fifty Day Average Change Percent | 0.04677099 |
| Fifty Two Week Change Percent | -26.800001 |
| Fifty Two Week High | 17.4 |
| Fifty Two Week High Change | -6.42 |
| Fifty Two Week High Change Percent | -0.36896554 |
| Fifty Two Week Low | 7.9 |
| Fifty Two Week Low Change | 3.0799994 |
| Fifty Two Week Low Change Percent | 0.38987336 |
| Fifty Two Week Range | 7.9 - 17.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,770,301,800,000 |
| Float Shares | 29,869,847 |
| Forward Eps | -6.33429 |
| Forward P E | -1.7334223 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 384 |
| Fullday Change | -0.540001 |
| Fullday Change Percent | -4.68751 |
| Fullday Price | 10.98 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.17377001 |
| Held Percent Institutions | 0.69184 |
| Implied Shares Outstanding | 54,165,030 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-02-05 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California. |
| Long Name | Eikon Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 594,732,032 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_638227772 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -322,160,992 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 623,439,495 |
| Number Of Analyst Opinions | 5 |
| Open | 11.41 |
| Operating Cashflow | -256,018,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 341 777 0566 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 10.98 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 11.52 |
| Price Eps Current Year | -1.7125156 |
| Price Hint | 2 |
| Price To Book | 1.2745211 |
| Profit Margins | 0.0 |
| Quick Ratio | 9.606 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.0 |
| Region | US |
| Regular Market Change | -0.540001 |
| Regular Market Change Percent | -4.68751 |
| Regular Market Day High | 11.44 |
| Regular Market Day Low | 10.9 |
| Regular Market Day Range | 10.9 - 11.44 |
| Regular Market Open | 11.41 |
| Regular Market Previous Close | 11.52 |
| Regular Market Price | 10.98 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 239,636 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 54,165,030 |
| Shares Percent Shares Out | 0.077199996 |
| Shares Short | 4,179,636 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 4,627,639 |
| Short Name | Eikon Therapeutics, Inc. |
| Short Percent Of Float | 0.1025 |
| Short Ratio | 12.79 |
| Source Interval | 15 |
| State | CA |
| Symbol | EIKN |
| Target High Price | 32.0 |
| Target Low Price | 4.0 |
| Target Mean Price | 24.6 |
| Target Median Price | 29.0 |
| Total Cash | 531,177,984 |
| Total Cash Per Share | 9.807 |
| Total Debt | 252,219,008 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -5.65 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 11.1267605 |
| Two Hundred Day Average Change | -0.14676094 |
| Two Hundred Day Average Change Percent | -0.013189907 |
| Type Disp | Equity |
| Volume | 239,636 |
| Website | https://eikontx.com |
| Zip | 94,030 |